[ad_1]
The study found that none of the 2,260 vaccinated children were infected with corona. The Pfizer vaccine is currently approved for people 16 years of age and older.
– This is a vaccine that has already been used many millions of times and has a temporary approval for use for 16 years, assistant health director Espen Nakstad tells Dagbladet.
– Then it remains to document that there are no problems with side effects and that it also shows a good effect in those under 16, he says.
– Things change fast
But the way the approval process is set up means it won’t be relevant until after the summer, Nakstad believes.
– It seems that the race that has been launched for approval means that this will not be relevant until after the summer. We don’t know for sure, but at least it appears that most adults will be offered vaccinations heading into the summer. In terms of time, this offer can appear after the adults have been vaccinated, Nakstad says.
– But things here also change quite quickly in terms of vaccine deliveries, he says.
In Europe, Pfizer-Biontech must seek approval from the European Medicines Agency (EMA) before the Norwegian Medicines Agency will accept such use.
It may take a few months
The process can take one to two months, according to Geir Bukholm, who directs the vaccine program at the National Institute of Public Health (NIPH).
– Then children up to twelve will be a group that we will eventually consider including in the vaccination program, Bukholm told NTB on Wednesday.
The corona vaccines from Pfizer, Moderna, AstraZeneca, and Johnson & Johnson are approved for use in Norway. The AstraZeneca vaccine has been discontinued following reports of possible serious side effects.
